235 related articles for article (PubMed ID: 15220007)
1. Jak3 and the pathogenesis of severe combined immunodeficiency.
O'Shea JJ; Husa M; Li D; Hofmann SR; Watford W; Roberts JL; Buckley RH; Changelian P; Candotti F
Mol Immunol; 2004 Jul; 41(6-7):727-37. PubMed ID: 15220007
[TBL] [Abstract][Full Text] [Related]
2. Jak3, severe combined immunodeficiency, and a new class of immunosuppressive drugs.
Pesu M; Candotti F; Husa M; Hofmann SR; Notarangelo LD; O'Shea JJ
Immunol Rev; 2005 Feb; 203():127-42. PubMed ID: 15661026
[TBL] [Abstract][Full Text] [Related]
3. Monocyte function in a severe combined immunodeficient patient with a donor splice site mutation in the Jak3 gene.
Villa A; Sironi M; Macchi P; Matteucci C; Notarangelo LD; Vezzoni P; Mantovani A
Blood; 1996 Aug; 88(3):817-23. PubMed ID: 8704236
[TBL] [Abstract][Full Text] [Related]
4. Mutations in severe combined immune deficiency (SCID) due to JAK3 deficiency.
Notarangelo LD; Mella P; Jones A; de Saint Basile G; Savoldi G; Cranston T; Vihinen M; Schumacher RF
Hum Mutat; 2001 Oct; 18(4):255-63. PubMed ID: 11668610
[TBL] [Abstract][Full Text] [Related]
5. Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development.
Russell SM; Tayebi N; Nakajima H; Riedy MC; Roberts JL; Aman MJ; Migone TS; Noguchi M; Markert ML; Buckley RH; O'Shea JJ; Leonard WJ
Science; 1995 Nov; 270(5237):797-800. PubMed ID: 7481768
[TBL] [Abstract][Full Text] [Related]
6. Eleven novel JAK3 mutations in patients with severe combined immunodeficiency-including the first patients with mutations in the kinase domain.
Mella P; Schumacher RF; Cranston T; de Saint Basile G; Savoldi G; Notarangelo LD
Hum Mutat; 2001 Oct; 18(4):355-6. PubMed ID: 11668621
[TBL] [Abstract][Full Text] [Related]
7. Impaired IL-7 signaling may explain a case of atypical JAK3-SCID.
Li J; Nara H; Rahman M; Juliana FM; Araki A; Asao H
Cytokine; 2010 Feb; 49(2):221-8. PubMed ID: 19889552
[TBL] [Abstract][Full Text] [Related]
8. Mutations in the gene for the IL-7 receptor result in T(-)B(+)NK(+) severe combined immunodeficiency disease.
Puel A; Leonard WJ
Curr Opin Immunol; 2000 Aug; 12(4):468-73. PubMed ID: 10899029
[TBL] [Abstract][Full Text] [Related]
9. Unexpected and variable phenotypes in a family with JAK3 deficiency.
Frucht DM; Gadina M; Jagadeesh GJ; Aksentijevich I; Takada K; Bleesing JJ; Nelson J; Muul LM; Perham G; Morgan G; Gerritsen EJ; Schumacher RF; Mella P; Veys PA; Fleisher TA; Kaminski ER; Notarangelo LD; O'Shea JJ; Candotti F
Genes Immun; 2001 Dec; 2(8):422-32. PubMed ID: 11781709
[TBL] [Abstract][Full Text] [Related]
10. Rapid protein-based assays for the diagnosis of T-B+ severe combined immunodeficiency.
Gilmour KC; Cranston T; Loughlin S; Gwyther J; Lester T; Espanol T; Hernandez M; Savoldi G; Davies EG; Abinun M; Kinnon C; Jones A; Gaspar HB
Br J Haematol; 2001 Mar; 112(3):671-6. PubMed ID: 11260071
[TBL] [Abstract][Full Text] [Related]
11. Severe combined immunodeficiencies of the common gamma-chain/JAK3 signaling pathway.
Schumacher RF; Notarangelo LD
Isr Med Assoc J; 2002 Feb; 4(2):131-5. PubMed ID: 11875988
[No Abstract] [Full Text] [Related]
12. Molecular modeling of the Jak3 kinase domains and structural basis for severe combined immunodeficiency.
Vihinen M; Villa A; Mella P; Schumacher RF; Savoldi G; O'Shea JJ; Candotti F; Notarangelo LD
Clin Immunol; 2000 Aug; 96(2):108-18. PubMed ID: 10900158
[TBL] [Abstract][Full Text] [Related]
13. In vitro correction of JAK3-deficient severe combined immunodeficiency by retroviral-mediated gene transduction.
Candotti F; Oakes SA; Johnston JA; Notarangelo LD; O'Shea JJ; Blaese RM
J Exp Med; 1996 Jun; 183(6):2687-92. PubMed ID: 8676091
[TBL] [Abstract][Full Text] [Related]
14. Autosomal SCID caused by a point mutation in the N-terminus of Jak3: mapping of the Jak3-receptor interaction domain.
Cacalano NA; Migone TS; Bazan F; Hanson EP; Chen M; Candotti F; O'Shea JJ; Johnston JA
EMBO J; 1999 Mar; 18(6):1549-58. PubMed ID: 10075926
[TBL] [Abstract][Full Text] [Related]
15. The role of Jak3 in lymphoid development, activation, and signaling.
Thomis DC; Berg LJ
Curr Opin Immunol; 1997 Aug; 9(4):541-7. PubMed ID: 9287175
[TBL] [Abstract][Full Text] [Related]
16. JAK3 inhibition as a new concept for immune suppression.
Borie DC; Si MS; Morris RE; Reitz BA; Changelian PS
Curr Opin Investig Drugs; 2003 Nov; 4(11):1297-303. PubMed ID: 14758768
[TBL] [Abstract][Full Text] [Related]
17. Structural and functional basis for JAK3-deficient severe combined immunodeficiency.
Candotti F; Oakes SA; Johnston JA; Giliani S; Schumacher RF; Mella P; Fiorini M; Ugazio AG; Badolato R; Notarangelo LD; Bozzi F; Macchi P; Strina D; Vezzoni P; Blaese RM; O'Shea JJ; Villa A
Blood; 1997 Nov; 90(10):3996-4003. PubMed ID: 9354668
[TBL] [Abstract][Full Text] [Related]
18. Development of autologous, oligoclonal, poorly functioning T lymphocytes in a patient with autosomal recessive severe combined immunodeficiency caused by defects of the Jak3 tyrosine kinase.
Brugnoni D; Notarangelo LD; Sottini A; Airò P; Pennacchio M; Mazzolari E; Signorini S; Candotti F; Villa A; Mella P; Vezzoni P; Cattaneo R; Ugazio AG; Imberti L
Blood; 1998 Feb; 91(3):949-55. PubMed ID: 9446656
[TBL] [Abstract][Full Text] [Related]
19. Self-selection by genetically modified committed lymphocyte precursors reverses the phenotype of JAK3-deficient mice without myeloablation.
Bunting KD; Lu T; Kelly PF; Sorrentino BP
Hum Gene Ther; 2000 Nov; 11(17):2353-64. PubMed ID: 11096440
[TBL] [Abstract][Full Text] [Related]
20. Cytokine-mediated signalling and early defects in lymphoid development.
Giliani S; Mella P; Savoldi G; Mazzolari E
Curr Opin Allergy Clin Immunol; 2005 Dec; 5(6):519-24. PubMed ID: 16264332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
